Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy D Henry

Showing results (411-420 of 573) with videos related to

Pageof 58
Sort By:
The American Journal of Cardiology|August 14, 2003
One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patientsF David Fortuin, Peter Vale, Douglas W Losordo, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|December 4, 2004
Standardized reporting guidelines for studies evaluating risk stratification of ED patients with potential acute coronary syndromesJudd E Hollander, Andra L Blomkalns, Gerard X Brogan, et al.
The American Journal of Cardiology|November 23, 2021
Frequency, Etiology, and Impact of Unplanned Repeat Coronary Angiography After ST-Elevation Myocardial InfarctionMehmet Yildiz, Raviteja R Guddeti, Daniel Shivapour, et al.
American Heart Journal|March 23, 2026
Enhancing Invasive Coronary Function Testing: Multivessel Assessment of Coronary Microvascular Dysfunction in Patients with Angina and No Obstructive Coronary Artery Disease (ANOCA)Andreas Tzoumas, Danielle N Tapp, Namrita Ashokprabu, et al.
Circulation. Cardiovascular Interventions|January 24, 2022
Autologous CD34+ Stem Cell Therapy Increases Coronary Flow Reserve and Reduces Angina in Patients With Coronary Microvascular DysfunctionTimothy D Henry, C Noel Bairey Merz, Janet Wei, et al.
The Journal of Invasive Cardiology|January 17, 2020
ST-Segment Elevation Myocardial Infarction and Out-of-Hospital Cardiac Arrest: Contemporary Management From the Multicenter START RegistryMeena Zareh, Jeffrey J Rade, Joseph L Thomas, et al.
Circulation Research|May 10, 2014
Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research networkRobert D Simari, Carl J Pepine, Jay H Traverse, et al.
JAMA Network Open|November 16, 2023
Mortality in ST-Segment Elevation Myocardial Infarction With Nonobstructive Coronary Arteries and MimickersOdayme Quesada, Mehmet Yildiz, Timothy D Henry, et al.
Scientific Reports|March 8, 2018
Author Correction: Circulating Biomarkers to Identify Responders in Cardiac Cell therapyJesse V Jokerst, Nicholas Cauwenberghs, Tatiana Kuznetsova, et al.
American Heart Journal|May 28, 2013
A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW studyThomas J Povsic, Candice Junge, Adel Nada, et al.
Pageof 58

Showing results (411-420 of 573) with videos related to

Sort By:
Pageof 58
The American Journal of Cardiology|August 14, 2003
One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patientsF David Fortuin, Peter Vale, Douglas W Losordo, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|December 4, 2004
Standardized reporting guidelines for studies evaluating risk stratification of ED patients with potential acute coronary syndromesJudd E Hollander, Andra L Blomkalns, Gerard X Brogan, et al.
The American Journal of Cardiology|November 23, 2021
Frequency, Etiology, and Impact of Unplanned Repeat Coronary Angiography After ST-Elevation Myocardial InfarctionMehmet Yildiz, Raviteja R Guddeti, Daniel Shivapour, et al.
American Heart Journal|March 23, 2026
Enhancing Invasive Coronary Function Testing: Multivessel Assessment of Coronary Microvascular Dysfunction in Patients with Angina and No Obstructive Coronary Artery Disease (ANOCA)Andreas Tzoumas, Danielle N Tapp, Namrita Ashokprabu, et al.
Circulation. Cardiovascular Interventions|January 24, 2022
Autologous CD34+ Stem Cell Therapy Increases Coronary Flow Reserve and Reduces Angina in Patients With Coronary Microvascular DysfunctionTimothy D Henry, C Noel Bairey Merz, Janet Wei, et al.
The Journal of Invasive Cardiology|January 17, 2020
ST-Segment Elevation Myocardial Infarction and Out-of-Hospital Cardiac Arrest: Contemporary Management From the Multicenter START RegistryMeena Zareh, Jeffrey J Rade, Joseph L Thomas, et al.
Circulation Research|May 10, 2014
Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research networkRobert D Simari, Carl J Pepine, Jay H Traverse, et al.
JAMA Network Open|November 16, 2023
Mortality in ST-Segment Elevation Myocardial Infarction With Nonobstructive Coronary Arteries and MimickersOdayme Quesada, Mehmet Yildiz, Timothy D Henry, et al.
Scientific Reports|March 8, 2018
Author Correction: Circulating Biomarkers to Identify Responders in Cardiac Cell therapyJesse V Jokerst, Nicholas Cauwenberghs, Tatiana Kuznetsova, et al.
American Heart Journal|May 28, 2013
A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW studyThomas J Povsic, Candice Junge, Adel Nada, et al.
Pageof 58